Skip to content

Functional T Cell Responses Are Associated With Prolonged HIV Control After Treatment Interruption.

Sep 2026 · Journal of Infectious Diseases · 0 citations
Medicine

TL;DR

Findings indicate that high pre-ATI Gag-specific IFN-γ and CD8+ T cell proliferation responses were associated with an increase in the duration of virological control after stopping ART, supporting a role for CD8+ T cells in sustaining virological control.

Abstract

Background

CD8+ T cell responses are thought to be critical for spontaneous control of human immunodeficiency virus (HIV) but findings supporting their role in post-intervention control have been mixed. We hypothesized that HIV-specific T cell proliferation, interferon-γ (IFN-γ) and granzyme B response prior to analytical treatment interruption (ATI) were associated with time to viral rebound.

Methods

We pooled data from six different HIV cure trials including people living with HIV receiving antiretroviral therapy (ART) alone or combined with latency reversing agents, Toll-Like receptor 9 agonists or broadly neutralizing antibodies. Pre-ATI blood samples were analysed by IFN-γ ELISpot and lymphocyte proliferation assay (LPA).

Results

We included 91 participants (90% male, median age 45 years). Compared to participants without virologic control (two consecutive measurements >1000 copies of HIV RNA/mL or ART restart), participants with virologic control at day 28 post-ATI (n=49) had higher Gag-specific IFN-γ (210 vs. 50 SFC/106 PBMCs, p=0.03) and CD8+ T cell proliferation (0.48% vs. 0.16%, p=0.03) responses pre-ATI. The median duration of virologic control was 28 vs. 21 days in people with high vs low Gag-specific IFN-γ response (p<0.01) or CD8+ T cell proliferation (p=0.03). ELISpot and LPA responses were not associated with time to first plasma HIV RNA of >50 copies/mL.

Conclusions

These findings indicate that high pre-ATI Gag-specific IFN-γ and CD8+ T cell proliferation responses were associated with an increase in the duration of virological control after stopping ART, supporting a role for CD8+ T cells in sustaining virological control.

View source

Similar papers

Open access Sep 2026

A mechanistic basis for CD8+ T cell expansion sensitivity as a predictor of HIV post-treatment control

The results provide a mechanistic explanation why both Ki-67+ responding CD8+ T cells and their TCF-1-expressing subset predict post-treatment control, linking clinical correlation to its underlying cause and highlighting Ki-67 and TCF-1 as potential early biomarkers of HIV immunotherapy success.

Tin Phan, Nicole Pagane, Jasmine A. F. Kreig et al. · 0 citations
Open access Aug 2026

Immune control of HIV viraemia in early paediatric infection is associated with induction of HIV-specific CD8+ T-cell activity following multiple treatment interruptions.

BACKGROUND Virus-specific CD8+ T-cells play an important part in HIV cure/remission in adults, yet their role in paediatric immune control is limited by tolerogenic early-life immunity. Very-early ART initiation, while effective in restricting viral reservoir size, also prevents antigenic exposure and, thereby, the ind...

Julia E. Edgar, H. R. Parker, C. Thobakgale et al. · 0 citations
Open access Aug 2026

Unique CD8 + T Cell Populations Expand during ART and Predict Delayed HIV-1 Rebound

Antiretroviral therapy (ART) suppresses HIV-1 replication but does not eliminate the latent reservoir, resulting in viral rebound with variable kinetics after treatment interruption. How the immune cell states established during ART influences timing of rebound is not fully understood. In this study, we analyzed 111 pa...

Jie Wang, Gautam Kundu, P. Ehrenberg et al. · 0 citations
Open access Aug 2026

Daily HIV pre-exposure prophylaxis enhances monocyte activation and reprogrammes immune cell metabolism

Introduction Pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine (TDF/FTC) is highly effective for HIV prevention. While antiretroviral therapy (ART) is linked to chronic inflammation in people living with HIV, its direct effects on immune phenotype, function, and metabolism in HIV-negative individuals remain...

G. Jameson, D. Murphy, Isabella Batten et al. · 0 citations
Open access Aug 2026

Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern

Chronic viral coinfections may contribute to persistent immune dysregulation in people with HIV, but their association with PD-1/PD-L1 expression remains uncertain. We analysed 100 people with HIV using available-case endpoint analyses and marker-specific paired baseline-to-follow-up analyses. Follow-up was scheduled a...

B. Aksak-Wąs, Karolina Skonieczna-Żydecka, D. Cembrowska-Lech et al. · 0 citations
Open access Sep 2026

Dynamics of virological suppression and systemic immune-inflammatory response following antiretroviral therapy in pediatric HIV infection

Background Persistent systemic inflammation remains a hallmark of treated HIV infection and is not reliably resolved by virological suppression alone. The Systemic Immune-Inflammation Index (SII), a composite hematologic index [(neutrophil × platelet)/lymphocyte count], has emerged as a candidate inflammatory biomarker...

Mavera Uşaklıoğlu Erol, Behiye Benaygül Kaçmaz, Ayper Somer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.